Twice-Yearly HIV Jab: Activists Call for Lower Prices
Explore the revolutionary Twice-Yearly HIV Jab, a potential game-changer in HIV prevention that raises important affordability questions.
Competition Commission probes insulin price fixing
The Competition Commission is investigating insulin manufacturers Novo Nordisk and Sanofi Aventis, raising concerns about accessibility to diabetes care.